What You Should Know:
- Babylon (NYSE: BBLN) acquires patient engagement platform DayToDay Health (“DayToDay”) to provide Babylon members with DayToDay’s digital-first, highly engaging programs and clinical services prior to and following scheduled surgeries, major health events like childbirth, and following diagnosis of chronic conditions.
- Financial details of the acquisition were not disclosed.
Enhancing Lives by Guiding Patients with Individualized Care
Although almost all
Read More
Casana Raises $30M for Effortless Home Health Monitoring
What You Should Know:
- Casana, a healthcare technology firm that is reinventing in-home health monitoring announced it has raised $30M in Series B funding, bringing the total capital raised to $46 million led by Morningside with participation from Matrix Partners, as well as Series A investors General Catalyst and Outsiders Fund.
- The Series B funding will allow Casana to accelerate FDA submission of the Heart Seat with the goal to obtain FDA approval and bring this important new device
Read More
M&A: IBM Sells Off Watson Health Business to PE Firm Francisco Partners
What You Should Know:
- Today, IBM announced it has sold off healthcare data and analytics assets from IBM that are currently part of the Watson Health business to global private equity firm Francisco Partners. The assets acquired by Francisco Partners include extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings.
- Financial terms of IBM's agreement with Francisco
Read More
Alphabet’s Verily + L’Oréal Partner to Advance Precision Skin Health
What You Should Know:
- Today, Alphabet’s Verily, a world leader in personalized medicine, and L’Oréal, the world leader in beauty, joined forces to lead a new era of precision skin health.
- The first-of-its-kind partnership in the beauty industry aims to break down barriers to dermatology care and bring new insights to dermatologists that can help improve health outcomes for the nearly two billion people worldwide with skin issues.
Strategic Partnership Addresses Unmet Need in
Read More
DarioHealth Acquires Physimax, AI-Powered Musculoskeletal Self-Assessment and Optimization Platform
What You Should Know:
- Global digital therapeutics (DTx) company DarioHealth Corp. (Nasdaq: DRIO), a leader in the market (the Company), announced it has entered into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. ("Physimax"), a leading provider of computer vision (CV) technology for Musculoskeletal (MSK) functional screening and predictive risk of injury assessment.
- This acquisition complements DarioHealth’s existing MSK
Read More
Theranica Publishes Largest Ever Real-World Study of a Migraine Device
What You Should Know:
- Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today the publication of a new peer-reviewed study analyzing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication adjunct, treatment of migraine.
- The real-world evidence study published in Frontiers in Pain Research Journal concludes that REN, administered by
Read More
Wheel Raises $150M to Expand White-Labeled Virtual Care Services
What You Should Know:
- Wheel, an Austin, TX-based provider of white-labeled virtual care services and support announced a $150M series C funding round, co-led by Lightspeed Venture Partners and Tiger Global, bringing its total funding to $216 million to date. The round also included participation from new investors Coatue and Salesforce Ventures along with existing investors CRV, Tusk Venture Partners and Silverton Partners.
Everything companies and clinicians need to deliver
Read More
Topography Health Launches out of Stealth with $27.5M to Empower Community Physicians to Run Clinical Drug Trials
What You Should Know:
- Topography Health, a clinical trials startup focused on community physicians, today launched out of stealth with $27.5M in funding from Andreessen Horowitz and Bain Capital Ventures.
- Co-founded by former Gerson Lehrman Group CEO Alexander Saint-Amand, Topography is making it possible for your family doctor to offer clinical drug trials as part of their practice. Not just for potentially terminal illnesses, but also for moderate chronic illnesses, where the
Read More
Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform
What You Should Know:
- Today, Sema4 (Nasdaq: SMFR), a health intelligence company, announced it has signed a definitive agreement to acquire GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million, strengthening its market-leading health intelligence and genomic screening offerings.
- The combined company is projected to deliver $350 million in pro forma 2022 revenue. In connection with the acquisition,
Read More
ONC Publishes the Trusted Exchange Framework and the Common Agreement
What You Should Know:
- The Office of the National Coordinator for Health IT (ONC) and its Recognized Coordinating Entity (RCE), The Sequoia Project, published the Trusted Exchange Framework and Common Agreement (TEFCA), creating the baseline legal and technical requirements that will enable secure, nationwide information sharing across different health care entities, completing a critical 21st Century Cures Act requirement.
- The release of TEFCA today marks the beginning of the
Read More
